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During the last few years, there has been a great interest in the
development of fast liquid chromatography. Among the reported
approaches, the reduction of the particle size to attain sub-2µm
diameter represents a good solution for achieving both increased
separation power and faster analysis time. This paper demonstrates
the chromatographic performance of such supports using plate-
height curves and reveals the possibility for obtaining ultra-fast or
highly efficient separations, according to the column geometry and
system pressure limitations. The stability of these columns is
initially evaluated using a system suitability experiment. The
chromatographic performance remains stable in terms of retention,
efficiency, and pressure for more than 1700 injections with
pressure conditions ranging from 200 to 800 bar. Several fast and
ultra-fast pharmaceutical applications are reported. In isocratic
mode, a 5- to 10-fold reduction in analysis time is obtained with
limited influence on efficiency and resolution. The run time is
further reduced by 30-fold with the shorter available columns (i.e.,
30 mm length). In gradient mode, the separation of a complex
mixture containing an active pharmaceutical compound and
related impurities is significantly improved with column length
equal to 100 mm, to increase peak capacity and resolution.
Introduction
High selectivity and fast analyses are two of the driving
forces of high-performance liquid chromatography (HPLC).
Most of the common pharmaceutical applications such as
purity assay, purity profiling, pharmacokinetic study, validation
procedure, and quality control necessitate fast and efficient
analytical procedures. The reduction in the average particle
size of chromatographic supports is a good approach for
achieving both increased separation power and faster analysis
time. In the past, several authors (1–6) demonstrated the
importance of small particles (around 1 to 2 µm) for improving
LC performance. In 1977, Knox stated (5) that for making full
use of the high pressure available from “modern pumps”, par-
ticles in the range 1–2 µm should be used to obtain t0 around
10 s and pressure drop lower than 200 bar. However, the
column length would be very short (from 20 to 40 mm)
because of pressure limitation. The same author (3) also indi-
cated the importance for working on injection and detection
miniaturization to get the full potential of LC.
Column manufacturers made much progress over the years
in terms of packing materials and chromatographic systems
(7–11). Improvements in particle production have resulted in
the commercial availability of small and highly uniform porous
silica supports. In the 70’s, columns packed with 10 µm parti-
cles were introduced; in the late 80’s, 5 µm became the stan-
dard diameter, while 3 µm particles were launched in the 90’s.
In 2004, the breakthrough finally came with the successful
introduction of sub-2 µm porous particles by Waters (12) and
several other providers (13,14). However, the pressure required
for pumping the mobile phase through a column packed with
such small particles can be prohibitive for standard HPLC
hardware because it is directly proportional to the cube of par-
ticle diameter at the optimal mobile phase flow rate, according
to the well-known Darcy’s law (7). Some improvements to the
chromatographic system have been made to address this
problem in terms of pumping units, injector valves, and
columns able to operate at extreme pressures. Jorgenson et al.
(15) developed an ultra high-pressure liquid chromatography
(UHPLC) system compatible with pressure 10-fold higher than
conventional LC (approximately 4,100 bar). In their work, 1.5
µm non-porous particles were used to obtain highly efficient
separations (140,000 < N < 190,000) within a reasonable
analysis time (less than 10 min). In 2003 (16), additional
improvements made their system compatible with pressure
up to 7,000 bar and non-porous columns packed with 1 µm
were used to attain efficiency up to 300,000 plates. Neverthe-
less, because of several problems reported in UHPLC for sample
introduction (17), safety concerns (18), solvent compressibility
(19), and frictional heating (20), 7,000 bar was difficult to
handle routinely (16).
In 2004, a commercial system capable of withstanding pres-
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sure up to 1000 bar, named ultra-performance liquid chro-
matography (UPLC), was successfully launched by Waters.
Currently, several other providers (i.e., Agilent Technologies,
Thermo Fisher Scientific, and Jasco, Inc.) propose systems
able to operate at pressure higher than 400 bar. Many appli-
cations can be found in the literature on the applicability of
such systems (21–25). Moreover, several reviews were dedi-
cated to UPLC (7,26) and a special issue of “Journal of
Separation Science” was devoted to this topic (27). A recent
comparison between the different providers demonstrated
that all instruments were able to provide reliable and repro-
ducible data (28). Comparison in terms of qualitative and
quantitative performance between UPLC and other analytical
approaches including conventional LC, monoliths, or high-
temperature liquid chromatography was also performed
(29,30). These studies demonstrated that UPLC represents
the most suitable strategy for reducing analysis time without
sacrificing quantitative performance and chromatographic
resolution.
This work describes the use of UPLC for the analysis of low
molecular weight drugs, using UV detection. The concepts and
benefits of columns packed with sub-2 µm particles at very
high-pressure conditions were assessed. For this purpose,
column packing stability and chromatographic performance
were evaluated for pressure ranging between 200 and 800 bar.
Several pharmaceutical applications in isocratic as well as gra-
dient mode demonstrated the possibility to obtain ultra-fast
and/or highly efficient separations in UPLC.
Experimental
Apparatus
Instrument for experiments performed with 5 µm particles
Separations with conventional LC 5 µm columns were per-
formed with a Merck LaChrom system (Merck, Darmstadt,
Germany) consisting of L-7100 programmable pumps, a L-
7200 auto-sampler with a 100 µL loop (injection of 10 µL for
both sets of conditions), a L-7614 on-line degasser, a L-4250
UV–vis programmable detector, and a column oven. The UV–vis
detector contained a 14 µL standard flow cell, the time con-
stant was set at 0.1 s, and data sampling rate was 10 Hz. Data
acquisition, data handling, and instrument control were per-
formed with the D-7000 HPLC System Manager Software
(Merck). Extra-column band broadening of this instrument
was estimated at approximately σ2ext = 200 µL2 at 1000 µL/min
(31) and dwell volume at Vd = 1.3 mL (32).
UPLC instrument for experiments performed
with sub-2 µm particles
Fast LC separations were performed with the Waters Acquity
UPLC system (Waters, Milford, MA), which can withstand pres-
sures up to 1000 bar. This instrument included a binary solvent
manager with a maximum delivery flow rate of 2 mL/min, an
auto-sampler with a 2 or 5 µL loop (depending on column
geometry), a UV–vis programmable detector, and a column
oven set at 30°C. The UV–vis detector contained a 500 nL flow
cell, the time constant was set at 25 ms, and data sampling at
80 Hz. Data acquisition, data handling, and instrument control
were performed by Empower Software (Waters). Extra-column
band broadening of this instrument was estimated at approx-
imately σ2ext = 5 µL2 at 600 µL/min (31) and dwell volume at
Vd = 0.13 mL for the 5 µL injection loop (32).
Chemicals and columns
Compounds used for qualitative comparison (uracil, methyl-
paraben, ethylparaben, propylparaben, and butylparaben) were
obtained from Sigma-Aldrich (Steinheim, Germany).
A formulation of Rapidocaïne 0.5% was provided by Sin-
tetica SA (Mendrisio, Switzerland). The active ingredient is
lidocaïne hydrochloride, a basic drug with a pKa of approxi-
mately 8 and a log P of approximately 2.36 (calculated using
Advanced Chemistry Development [ACD/Labs] Software V8.14
for Solaris [1994–2006 ACD/Labs]). Lidocaïne hydrochloride
was obtained from Sigma-Aldrich (Steinheim, Germany) and
2,6-dimethylaniline from Fluka (Buchs, Switzerland). The
latter was added in the formulation at a concentration of
5 µg/L.
Bromazepam, nitrazepam, oxazepam, clonazepam, alpra-
zolam, flunitrazepam, and diazepam were purchased from
Lipomed AG (Arlesheim, Switzerland) as stock standard solu-
tions at 1 mg/mL in MeOH and stored at 4°C until use. These
compounds possess weak basic moieties, with an average pKa
value of 2.
Finally, an active substance (AC) was provided as standard by
a pharmaceutical company with process-related substances,
other impurities, and degradation compounds.
Acetonitrile was of HPLC gradient grade from Panreac
Quimica (Barcelona, Spain). Water was obtained from a Milli-
Q Waters Purification System from Millipore (Bedford, MA).
Formic acid was obtained from SDS (Peypin, France). Aqueous
phosphate buffer 50mM at pH 7.2 was prepared with an equiv-
alent quantity of di-potassium hydrogen phosphate anhydrous
(Fluka, Buchs, Switzerland) and potassium dihydrogen phos-
phate (Fluka). Aqueous acetate buffer 50mM pH 7 consisted of
a 50mM ammonium acetate buffer (Fluka) adjusted with
ammonia. The pH was measured with a Metrohm pH meter
(Herisau, Switzerland) and corresponded to the aqueous pH
value.
Columns used throughout this study were Hypersil GOLD
C18 supports, provided by Thermo Fisher Scientific (Runcorn,
UK). Various column geometries were used: 150 × 4.6 mm,
5 µm; 30 × 2.1 mm, 1.9 µm; 50 × 2.1 mm, 1.9 µm; and 100 ×
2.1 mm, 1.9 µm.
Methodology for method transfer
A methodology has been described elsewhere (31,32) for
transferring a chromatographic separation performed with a
given column geometry and chemistry to a column packed
with similar or identical stationary phase, without influence on
chromatographic performance.
Briefly, in isocratic mode (31), the injection volume and
mobile phase flow-rate should be adapted while the mobile
phase composition, nature, and temperature remained iden-
tical to the original method. A suitable instrumentation must
Journal of Chromatographic Science, Vol. 46, March 2008
201
be used, particularly with smaller column dimensions, to limit
the negative influence of extra-column band broadening on the
separation performance.
In gradient mode (32), injection volume and mobile phase
flow rate should be adapted as in isocratic mode. Regarding the
gradient profile, it is important to scale the gradient volume in
proportion to the column volume to yield identical elution
patterns, using simple scaling equations. In gradient mode,
special attention should be paid to the dwell volume (gradient
delay volume), which causes the most detrimental effect during
method transfer.
Optimal conditions for method transfer were established in
isocratic and gradient mode using a freely usable Excel pro-
gram distributed on an internal website (33).
Results and Discussion
Column stability
The routine use of columns packed with sub-2 µm particles
remains quite recent and the few published studies only con-
cerned hybrid silica-based stationary phases provided by
Waters. These works demonstrated a very good resistance of
the support in high-pressure conditions with up to 4000 injec-
tions (34) or 1000 injections at pH 11.3 (35). Because the
columns used throughout the present study were provided by
another supplier, no indications concerning stability were
available.
For this purpose, a test mixture consisted of 4 parabens and
uracil was injected into the system with pressure conditions
ranging from 200 to 800 bar. The mobile phase was unbuffered
(i.e., ACN–water mixture [40:60, v/v]) and constantly pumped
through the column at a flow rate comprised between 300 and
1320 µL/min (to achieve adequate pressures). With the 50 mm
column length, 500 injections were initially performed at 200
bar (representing approximately 3000 column volumes) fol-
lowed by 500 additional injections at 400 bar. Then, 300 injec-
tions were carried out at 600 bar and finally 400 injections at
800 bar. To summarize, the column was tested with 1700 injec-
tions, equivalent to approximately 10000 column volumes,
with a sequential increase in flow rate.
Chromatographic performance was evaluated by means of
efficiency (N), retention factor (k), asymmetry at 10% of peak
height (As), and column backpressure (∆P). Uracil was used for
determining column dead volume. Only results of efficiency
have been reported in Figure 1. Chromatographic parameters
(N, k, or As) varied with pressure conditions because of flow
rate changes (between 300 and 1320 µL/min). Therefore, each
parameter was plotted on a relative scale (%), to directly com-
pare results independently of the applied flow rate.
No significant change in efficiency was observed for the four
tested compounds after 1700 injections under high pressure up
to 800 bar. Corresponding relative standard deviations were
between 0.8% and 1.1%. Regarding As, initial tailing values
were comprised between 1.3 for methylparaben and 1.06 for
butylparaben. When pressure increased up to 800 bar, As values
decreased by approximately 10%, and final values were in the
range 0.98–1.15. Therefore, a long-term exposure to high pres-
sure did not appear detrimental for peak shape. Finally, k was
stable after 1700 injections (data not shown) with a variation
lower than 0.2% from the beginning to the end of the tested
period.
Chromatograms acquired during the stability study are given
in Figures 2A and 2B for the highest tested pressures. Chro-
matograms periodically obtained were overlaid at each pres-
sure, and no significant differences were observed on the
quality of the separation after a significant number of injec-
tions. Furthermore, retention time changed less than 1 s at the
highest pressure. Consequently, the reliability of the tested
sub-2 µm chromatographic support was considered accept-
able.
Figure 1. Stability study of Hypersil GOLD 50 × 2.1 mm, 1.9 µm column:
variation of efficiency for the four selected parabens: 500 injections at 200
bar and F = 300 µL/min, 500 injections at 400 bar and F = 640 µL/min, 300
injections at 600 bar and 960 µL/min, and finally 400 injections at 800 bar
and F = 1320 µL/min.
Figure 2. Evaluation of column repeatability at 600 and 800 bar: repetition
of a system suitability experiment (separation of uracil and 4 parabens).
Overlaid chromatograms for injection: 1, 50, 100, 150, 200, 250, and 300
at a pressure of 600 bar (A). Overlaid chromatograms for injection: 1, 50,
100, 150, 200, 250, 300, 350, and 400 at a pressure of 800 bar (B).
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Chromatographic performance
Performance of columns packed with 5 and 1.9 µm was
compared and corresponding plate height curves plotted in
Figure 3A for butylparaben at 30°C (kbutylparaben = 5). Least
square regression was employed to fit experimental data
(H, u) with H = A + B/u + Cu, derived from the Van Deemter
equation.
When particle size decreased, Hopt value diminished pro-
portionally, from 11.1 to 4.9 µm. Therefore, for an equivalent
column length, N value was improved by a factor 2.3. From a
theoretical point of view, N should be increased by a factor 2.6
(ratio 5 µm/1.9 µm). Because extra-column contributions were
negligible for butylparaben (k = 5), this discrepancy could be
attributed to the packing procedure (it is more difficult to
homogeneously pack columns with sub-2 µm particles) or to
the influence of particle size distribution, as recently demon-
strated with sub-2 µm particles (36). Nevertheless, both
columns presented an acceptable theoretical hopt (5) equal to
2.21 and 2.57 with 5 and 1.9 µm particles, respectively. The
optimal mobile phase velocity (uopt) increased from 1.2 to 3.2
mm/s for a particle size reduction from 5 to 1.9 µm, leading to
a reduction in analysis time in agreement with theory (uopt ×
dp = cte). The mass transfer resistance (i.e., C term of the H =
f[u] equation, corresponding to the right part of the plate
height curve) was significantly improved, allowing the appli-
Figure 3. Effect of particle size on the chromatographic performance of
Hypersil GOLD support. Solute: Buytlparaben. Van Deemter curves H = f(u)
for:  = 150 × 4.6 mm, 5 µm, and  = 50 × 2.1 mm, 1.9 µm.
Figure 4. Chromatogram of a mixture containing uracil and 4 parabens on
Hypersil GOLD supports in isocratic conditions with a mobile phase
ACN–water (40:60, v/v), T = 30ºC, λ = 254 nm. Column 150 × 4.6 mm, 5
µm, F = 800 µL/min, and Vinj = 20 µL (A). Column 50 × 2.1 mm, 1.9 µm,
F = 440 µL/min, and Vinj = 2 µL (B). Column 30 × 2.1 mm, 1.9 µm, F = 440
µL/min, and Vinj = 1.5 µL (C). Column 50 × 2.1 mm, 1.9 µm, F = 1320
µL/min, and Vinj = 2 µL (D). Column 30 × 2.1 mm, 1.9 µm, F = 1640
µL/min, and Vinj = 1.5 µL (E). Elution order: uracil, methylparaben, ethyl-
paraben, propylparaben, butylparaben; each at 50 mg/L.
Figure 5. Chromatogram of reconstituted rapidocaïne formulation obtained
in isocratic mode with a mobile phase containing ACN–water (40:60, v/v)
with phosphate buffer 50 mM at pH 7, T = 30ºC, λ = 230 nm. Hypersil
GOLD 150 × 4.6 mm, 5 µm, F = 1000 µL/min, Vinj = 20 µL (A). Hypersil
GOLD 50 × 2.1 mm, 1.9 µm, F = 550 µL/min, Vinj = 1.4 µL (B). Hypersil
GOLD 50 × 2.1 mm, 1.9 µm, F = 1300 µL/min, Vinj = 1.4 µL (C). Hypersil
GOLD 30 × 2.1 mm, 1.9 µm, F = 1600 µL/min, Vinj = 0.8 µL (D). Elution
order: 1, methylparaben at 0.08 mg/L; 2, 2,6-dimethylaniline at 0.005
mg/L; 3, propylparaben at 0.01 mg/L; 4, lidocaïne hydrochloride at
500 mg/L.
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cation of higher flow rates than its optimal value without sig-
nificant reduction in N. At the highest tested flow rate, only
25% loss in efficiency was reported on the column packed
with 1.9 µm particles.
The variation of pressure with flow rate was not reported, but
clearly remained the limiting parameter for columns packed
with sub-2 µm particles, as discussed elsewhere (7,14,30).
However, with column and instrumentation compatible with
very high pressure, the potential of sub-2 µm could be fully
exploited (30).
Chromatograms obtained on the tested column geometries
with the test mixture of parabens are shown in Figure 4. Cor-
responding N, As, minimal Rs, ∆P, and analysis times are
reported in Table I. Performance achieved at the optimal flow
rate (800 µL/min), with the conventional 150 × 4.6 mm, 5 µm
column was excellent with an efficiency of 13500 plates for
Table I. Evaluation of Chromatographic Performance for Isocratic Separations of Parabens Given in Figure 4; Data are
Given for Methylparaben (peak 2) and Butylparaben (peak 5)
5 µm Sub-2 µm
150 × 4.6 mm 50 × 2.1 mm 30 × 2.1 mm
800 µL/min 440 µL/min 1000 µL/min 1320 µL/min 440 µL/min 1000 µL/min 1640 µL/min
Efficiency 13500 8100 6600 6100 3800 3200 3000
(peak 2)
Asymmetry 1.13 1.19 1.16 1.12 1.76 1.7 1.59
(peak 2)
Efficiency 13500 10300 8500 7400 5800 4900 4000
(peak 5)
Asymmetry 1.12 1.02 1.01 0.94 1.34 1.46 1.35
(peak 5)
Most critical 7.8 6.7 5.9 5.6 4.4 3.9 3.6
resolution
Pressure 70 280 610 790 220 470 740
(bar)
Analysis time – 6 14 18 10 23 36
reduction
Table II. Evaluation of Chromatographic Performance for Isocratic Separations of Rapidocaïne Formulation Given in
Figure 5; Data are Given for 2,6-Dimethylaniline (peak 2) and Lidocaïne Hydrochloride (peak 4)
5 µm Sub-2 µm
150 × 4.6 mm 50 × 2.1 mm 30 × 2.1 mm
1 µL/min 550 µL/min 1000 µL/min 1300 µL/min 550 µL/min 1000 µL/min 1600 µL/min
Efficiency 12900 10700 9000 7800 5900 4900 3900
(peak 2) 
Asymmetry 1.13 1.06 1.07 1.03 1.4 1.37 1.18
(peak 2)
Efficiency 10400 7300 6300 5600 4600 4000 3200
(peak 4)
Asymmetry 1.15 0.85 0.83 0.81 1.11 1.15 1.1
(peak 4)
Most critical 3.7 3.42 3.17 3.05 2.4 2.21 2.01
resolution
Analysis time – 6 12 16 10 20 28
reduction
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methyl- and butyl-paraben, and an average As of 1.1. How-
ever, the analysis time was 11 min and should not be reduced
because N dramatically decreased at higher flow rate.
With the 50 × 2.1 mm, 1.9 µm column, in optimal flow
rate conditions (440 µL/min) (Figure 4B), the separation was
satisfactory, with an efficiency of 8100 for methylparaben and
10300 for butylparaben, and asymmetry values similar to
those obtained previously (Table I). The low efficiency observed
for the former, with a retention factor of 2, was attributed to
extra-column contributions. Nevertheless, on these condi-
tions, the backpressure was only of ca. 280 bar, demonstrating
that columns packed with sub-2 µm particles are compatible
with conventional HPLC equipment in terms of pressure but
requires a special attention to extra-column volumes. When
the flow rate was increased to its maximum value, efficiency
dropped significantly but the separation remained satisfac-
tory and the analysis time was reduced 18-fold, as shown in
Figure 4D.
Finally, resolution obtained with the 30 × 2.1 mm, 1.9 µm
column was still sufficient but with significant efficiency reduc-
tion, because extra-column volume contributions were pre-
dominant with this shorter column length. Separations
presented in Figures 4C (440 µL/min) and 4E (1640 µL/min)
were acceptable in terms of minimal resolution with analysis
time reduced by a factor 36 (ca. 20 s).
Applications
Several case studies were developed in isocratic and gra-
dient modes to illustrate the applicability and benefits of par-
ticle reduction in pharmaceutical analysis (quality control,
screening method, or purity profiling).
Quality control: rapidocaïne formulation in isocratic mode
Rapidocaïne is a pharmaceutical for-
mulation containing lidocaïne hydro-
chloride, a local anaesthetic known for
its cardiac anti-arrhythmia properties
and two preservatives, methylparaben
and propylparaben. A potential degrada-
tion product, 2,6-dimethylaniline, was
also added to the formulation for this
study to assess selectivity. Chro-
matograms obtained are given in Figure
5 and associated data summarized in
Table II.
The method was originally developed
on a Hypersil GOLD 150 × 4.6 mm, 5 µm
column at a flow rate of 1 mL/min with
phosphate buffer at pH 7.2. The separa-
tion (Figure 5A) demonstrated N values in
the expected range, varying from 12900
for 2,6-dimethylaniline to 10400 for lido-
caïne hydrochloride. The low N of the
latter was due to injection overloading
necessary to simultaneously detect its
degradation product, which could be pre-
sent at very low level. Minimal resolution
between peaks 2 and 3 was equal to 3.7 for
Figure 6. Separation of a benzodiazepines mixture in isocratic mode with
a mobile phase containing ACN–water (31:69, v/v) with 0.1% formic
acid, T = 30°C, and λ = 254 nm. Hypersil GOLD 150 × 4.6 mm, 5 µm, F
= 1000 µL/min, Vinj = 20 µL (A). Hypersil GOLD 50 × 2.1 mm, 1.9 µm,
F = 550 µL/min, Vinj = 1.4 µL (B). Hypersil GOLD 50 × 2.1 mm, 1.9 µm,
F = 1000 µL/min, Vinj = 1.4 µL (C). Hypersil GOLD 50 × 2.1 mm, 1.9 µm,
F = 1320 µL/min, Vinj = 1.4 µL (D). Elution order: 1, bromazepam; 2,
nitrazepam; 3, oxazepam; 4, clonazepam; 5, alprazolam; 6, flunitrazepam;
and 7, diazepam, each at 10 mg/L.
Table III. Evaluation of Chromatographic Performance for Isocratic Separations
of Benzodiazepines Given in Figure 6; Data are Given for Nitrazepam (peak 2)
and Diazepam (peak 7)
5 µm sub-2 µm
150 × 4.6 mm 50 × 2.1 mm
1 mL/min 550 µL/min 1000 µL/min 1320 µL/min
Efficiency  11900 9700 7300 6000
(peak 2)
Asymmetry 0.93 1.07 1.02 0.94
(peak 2)
Efficiency  12200 9500 7800 6600
(peak 7)
Asymmetry 0.94 0.98 0.94 0.95
(peak 7)
Most critical 2.09 1.93 1.8 1.65
resolution
Analysis time – 6 12 17
reduction
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a 9 min analysis time. 
This separation was transferred to
shorter columns packed with sub-2 µm
particles using the basic rules given in the
literature (31,32). With the column of 50
mm at the geometrical transferred flow
rate (F = 550 µL/min), performance was
slightly altered in terms of resolution while
the analysis time was reduced by a factor 6,
as shown in Figure 5B. At a higher mobile
phase flow rate, the resolution was reduced
by 15% to 20% as shown in Table II and
Figure 5C, but remained acceptable (Rs >
3), while a 12- to 16-fold reduction in
analysis time was observed at F = 1000 and
1300 µL/min, respectively.
With the column of 30 mm and
according to previous observations (Figure
3B), efficiency was reduced by approxi-
mately 45%, leading to a minimal resolu-
tion of 2.4 and 2, at flow rates of 550 and
1600 µL/min, respectively. Therefore, the
separation obtained at the maximal flow
rate with this column (Figure 5D) is suffi-
cient to perform routine analyses in only
20 s.
Toxicological screening: benzodiazepines
in isocratic mode
Benzodiazepines belong to a group of
substances known for their tranquillizing,
hypnotic, and anticonvulsant properties
(37). These compounds possess weak
basic moieties with average pKa of
approximately 2. A simple and rapid pro-
cedure in isocratic mode was developed
for the simultaneous determination of
seven benzodiazepines. Chromatograms
obtained are given in Figure 6 and
related data summarized in Table III.
The original method was developed on
a conventional 150 × 4.6 mm, 5 µm
column at a flow rate of 1 mL/min, with a
mobile phase containing ACN–water
(31:69, v/v) and 0.1% formic acid. The
corresponding separation is given in
Figure 6A and took 20 min, with a min-
imal resolution between peaks 2 and 3 of
2.09 (average efficiency was 12000).
The method was transferred to a
shorter column packed with 1.9 µm par-
ticles. The chromatogram obtained at
the optimal flow rate (550 µL/min) is
given in Figure 6B with an analysis time
reduced by a factor 6. N decreased by
20% (in agreement with previous obser-
vations) and resolution of only 8%. With
larger f low rates (1000 and 1320
Figure 7. Separation of active compound and 9 related impurities in gradient mode with a mobile phase
containing acetonitrile and ammonium acetate 50mM pH 7. T = 30°C and λ = 254 nm. Hypersil
GOLD 150 × 4.6 mm, 5 µm, F = 1000 µL/min, Vinj = 20 µL, gradient profile: 38–46% ACN in 25 min
and 5 min step at the end of the gradient (A). Hypersil GOLD 50 × 2.1 mm, 1.9 µm, F = 550 µL/min, Vinj
= 1.4 µL, gradient profile: 38–46% ACN in 3.16 min and 0.63 min step at the end of the gradient (B).
Hypersil GOLD 50 × 2.1 mm, 1.9 µm, F = 1000 µL/min, Vinj = 1.4 µL, gradient profile: 38–46% ACN
in 1.74 min and 0.34 min step at the end of the gradient (C). Hypersil GOLD 100 × 2.1 mm, 1.9 µm, F
= 550 µL/min, Vinj = 2.8 µL, gradient profile: 38–46% ACN in 6.32 min and 1.26 min step at the end of
the gradient (D). Main compound concentration: 600 ppm and each impurity at 30 ppm.
Table IV. Evaluation of Chromatographic Performance for Gradient Separations
of Main Compound and Related Impurities Given in Figure 7 
5 µm sub-2 µm
150 × 4.6 mm 50 × 2.1 mm 100 × 2.1 mm
1 mL/min 550 µL/min 1000 µL/min 1300 µL/min 550 µL/min
Most critical 1.82 1.88 1.75 1.65 3.11
resolution (classic)
Most critical 1.59 1.62 1.41 1.3 2.72
resolution (modified)
Resolution 3.4 3.71 3.36 3.06 5.6
peaks 6–7
Analysis 25.2 3.8 2 1.6 7.5
time (min)
Analysis – 6 12 16 3.5
time reduction
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µL/min), efficiency was reduced by 35% and 45%, respec-
tively, leading to an acceptable loss in resolution of 15% and
20%. As shown in Figures 6C and 6D, analysis times
decreased 12- and 17-fold at 1000 and 1320 µL/min, respec-
tively.
With the strict geometrical transfer (Figures 6A and 6B),
selectivity was not altered, while at higher flow rate (Figures 6C
and 6D), k of alprazolam (i.e., peak 5) significantly varied. This
unexpected behavior suggested that the elevated backpressure
conditions (comprised between 600 and 800 bar) lead to unde-
sired phenomena such as frictional heating (causing thermal
gradient inside the column). However, this modification was
not critical because resolution always remained sufficient.
Purity profiling: active compound and 
related substances in gradient mode
A fundamental shortcoming of conventional HPLC is its
limited resolving power, particularly for analyzing very complex
mixtures. For years, the maximal achievable number of plates
within an acceptable analysis time (less than 1 h) was limited
to approximately 20,000 plates, but UPLC technology could sig-
nificantly overcome this limit. Several authors experimentally
demonstrated its potential for separations requiring a high
resolution (38,39), and on the basis of theoretical kinetic plots
(40–42). In the pharmaceutical industry, the resolving power
is a key parameter because it is of primary importance in devel-
oping analytical methods able to separate an active compound
from its process-related substances, other impurities, and
degradation compounds, for quantitative purity assay or purity
profiling. As example, an active pharmaceutical ingredient was
selected as the model compound with nine related compounds.
Chromatograms obtained with this mixture are given in Figure
7 and data are summarized in Table IV. The original separation
was performed in approximately 27 min on a conventional
150 × 4.6 mm, 5 µm column at a flow rate of 1 mL/min. Suit-
able chromatographic conditions were found thanks to HPLC
modelling software (Osiris, Datalys, Grenoble, France). The
latter quickly determined optimal conditions for the separation
with two initial gradient runs (gradient slope of 1% and
3%/min) at a given pH and temperature. Thus, the chro-
matogram in Figure 7A corresponded to the highest resolution
for the least separated pair of peaks, provided that the resolu-
tion was higher than 1.5 and k in the range 1–10. 
In the case of purity profiling, the active compound was not
at the same concentration as other process-related substances
(600 ppm vs. 30 ppm). Therefore, minimal resolution between
peak 3 and “AC” was evaluated in two ways and both values are
reported in Table IV. The first method was based on the basic
equation of resolution:
Rs = 
2(tr2 – tr1)
Eq. 1_________
Wb1 + Wb2
where tr2 and tr1 are the retention times of two adjacent peaks;
Wb1 and Wb2 are base-widths of the two peaks. The second
approach takes into account differences in peak height (43) and
gives a more reliable estimation of resolution:
Rs = 
(tr2 – tr1)
•
√
__
N
Eq. 2____________________________
tr1 + tr2 • 1 + 0.5ln
h2
where h1 and h2 are the peak heights of two adjacent peaks. N
is the average chromatographic efficiency (assumed to be iden-
tical for both peaks).
Using equation 1, the minimal resolution between peak 3
and “AC” was equal to 1.82, while with equation 2, minimal res-
olution was reduced to an acceptable value of 1.59 for the sep-
aration presented in Figure 7A. This method was thus
transferred to a 50 mm column packed with 1.9 µm particles.
The optimal flow rate was found at 550 µL/min, the injected
quantity 1.4 µL, and the gradient time was changed from 25 to
only 3.2 min. The corresponding chromatogram is given in
Figure 7B. Additionally, a 6-fold reduction in the overall
analysis time (separation and reconditioning) was observed.
The mobile phase flow rate was further increased to 1000 and
1300 µL/min. In gradient mode, it is mandatory to readapt
the gradient profile when changing mobile phase flow rate
(32). Gradient time was thus reduced to 1.7 and 1.3 min at
1000 (Figure 7C) and 1300 µL/min, leading to an overall
analysis time reduction of 12- to 16-fold, compared to con-
ventional LC experiments. However, in such conditions, reso-
lution between peak 3 and “AC” calculated with equation 2
became lower than 1.5 (Rs = 1.41 at 1000 µL/min and 1.3 at
1300 µL/min), as shown in Figure 7C.
When dealing with a complex mixture and critical resolu-
tions, longer columns can be used to increase substantially effi-
ciency and peak capacity. Therefore, a 100 mm column length
(generating approximately 20000 theoretical plates) was eval-
uated for the separation of the active compound and related
substances. Because the generated backpressure is directly
proportional to column length, maximal acceptable flow rate
was 550 µL/min. In such conditions, gradient run was reduced
to 6.3 min and the corresponding chromatogram is given in
Figure 7D. The analysis time was reduced by a factor of 3.5
compared to Figure 7A, and average resolution increased by
70% compared to the original method. This example demon-
strated the possibility of obtaining highly efficient separations
with sub-2 µm supports, when analysis time is not the main
issue.
Conclusions
In this study, column stability was initially evaluated up to
800 bar in terms of efficiency, asymmetry, retention factor,
and pressure. The evaluated sub-2 µm support remained still
usable after 1700 injections in unbuffered mobile phase and
very high-pressure conditions. 
This work also clearly demonstrated the potential of 1.9 µm
supports to obtain ultra-fast or highly efficient separations by
simultaneously using very high pressure and mobile phase
linear velocity. Several analytical methods (quality control,
√ ( )h1 2
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screening method, or purity profiling) originally developed in
isocratic or gradient modes, were transferred to illustrate the
benefits and limitations of the new UPLC technology. For a
simple pharmaceutical formulation and for the separation of
numerous benzodiazepines in isocratic mode, the analysis
time was reduced 15- and 30-fold with columns of 50 and 30
mm, respectively, while resolution remained acceptable even at
the maximal backpressure. For a complex purity profiling in
gradient mode, the analysis time was reduced 6-fold with a
column of 50 mm, with no loss in resolution. A 2-fold improve-
ment in resolution was also observed for a longer column (i.e.,
100 mm) packed with the same small particles while the
analysis time was reduced by a factor of 3. 
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